APA (7th ed.) Citation

Garnero, P., Sornay-Rendu, E., Munoz, F., Borel, O., & Chapurlat, R. (2013). Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: The OFELY study. Osteoporosis International, 24(2), 489. https://doi.org/10.1007/s00198-012-1978-x

Chicago Style (17th ed.) Citation

Garnero, P., E. Sornay-Rendu, F. Munoz, O. Borel, and R. Chapurlat. "Association of Serum Sclerostin with Bone Mineral Density, Bone Turnover, Steroid and Parathyroid Hormones, and Fracture Risk in Postmenopausal Women: The OFELY Study." Osteoporosis International 24, no. 2 (2013): 489. https://doi.org/10.1007/s00198-012-1978-x.

MLA (9th ed.) Citation

Garnero, P., et al. "Association of Serum Sclerostin with Bone Mineral Density, Bone Turnover, Steroid and Parathyroid Hormones, and Fracture Risk in Postmenopausal Women: The OFELY Study." Osteoporosis International, vol. 24, no. 2, 2013, p. 489, https://doi.org/10.1007/s00198-012-1978-x.